InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,954.63
(
2.30%
)

Replies to post #89653 on $heff's $tation of $tocks & $olid DD

Replies to #89653 on $heff's $tation of $tocks & $olid DD

$heff

12/23/15 9:18 AM

#92140 RE: $heff #89653

$KMDA.. pivotal Phase 2/3 trial with human rabies immune globulin meets primary endpoint. BLA mid 2016.
http://finance.yahoo.com/news/kamada-human-rabies-immune-globulin-110000699.html?soc_src=mediacontentstory&soc_trk=tw